Yu-Xia Zhao Selected Research

Dual Specificity Phosphatase 6

1/2018	Dual-specificity phosphatase 6 genetic variants associated with risk of lung squamous cell carcinoma in Han Chinese.
2/2017	Association of Topoisomerase II (TOP2A) and Dual-Specificity Phosphatase 6 (DUSP6) Single Nucleotide Polymorphisms with Radiation Treatment Response and Prognosis of Lung Cancer in Han Chinese.
1/2016	Dual Specificity Phosphatase 6 (DUSP6) Polymorphism Predicts Prognosis of Inoperable Non-Small Cell Lung Cancer after Chemoradiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Xia Zhao Research Topics

Disease

4	Lung Neoplasms (Lung Cancer) 02/2021 - 01/2015
4	Atherosclerosis 07/2013 - 01/2007
3	Heart Failure 01/2019 - 02/2015
3	Fibrosis (Cirrhosis) 01/2018 - 07/2014
3	Hypertension (High Blood Pressure) 02/2015 - 11/2009
3	Hypoxia (Hypoxemia) 01/2014 - 01/2013
2	Radiation Pneumonitis 01/2019 - 07/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 09/2014
2	Neoplasms (Cancer) 02/2017 - 01/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2017 - 01/2016
2	Coronary Disease (Coronary Heart Disease) 02/2015 - 01/2006
2	Bronchiolitis 01/2015 - 01/2015
2	Infarction (Infarctions) 05/2014 - 01/2013
2	Inflammation (Inflammations) 07/2013 - 07/2012
2	Myocardial Infarction 01/2013 - 01/2013
2	Unstable Angina 06/2009 - 11/2008
1	Brain Neoplasms (Brain Tumor) 02/2021
1	Neoplasm Metastasis (Metastasis) 02/2021
1	Diabetic Cardiomyopathies 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Abdominal Aortic Aneurysm 01/2018
1	Weight Loss (Weight Reduction) 02/2017
1	Wounds and Injuries (Trauma) 01/2016
1	Stomach Neoplasms (Stomach Cancer) 05/2015
1	Cardiac Arrhythmias (Arrythmia) 02/2015
1	Metabolic Diseases (Metabolic Disease) 01/2015
1	Lung Injury 01/2015
1	Carcinogenesis 09/2014
1	Nasopharyngeal Carcinoma 09/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2014
1	Radiation Injuries (Radiation Sickness) 07/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2014
1	Gliosis 06/2014
1	Vision Disorders (Hemeralopia) 01/2013
1	Ischemia 01/2013
1	Eye Diseases (Eye Disease) 01/2013
1	Ventricular Remodeling 01/2013
1	Atherosclerotic Plaque (Atheroma) 07/2012
1	Hypercholesterolemia 07/2012
1	Mood Disorders (Mood Disorder) 08/2010
1	Anxiety Disorders (Anxiety Disorder) 08/2010
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/2009
1	Angina Pectoris 06/2009
1	Death (Near-Death Experience) 11/2008

Drug/Important Bio-Agent (IBA)

3	tongxinluoIBA 01/2019 - 01/2013
3	Dual Specificity Phosphatase 6IBA 01/2018 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 02/2015 - 07/2013
3	CytokinesIBA 01/2015 - 07/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 07/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2013
2	C-Reactive ProteinIBA 01/2019 - 07/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 09/2014 - 07/2013
2	Retinaldehyde (Retinal)IBA 06/2014 - 01/2013
2	erucylphosphocholineIBA 05/2014 - 01/2013
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2014 - 01/2013
1	SteroidsIBA 01/2019
1	Angiotensin IIIBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	Apolipoproteins E (ApoE)IBA 01/2018
1	CollagenIBA 01/2018
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	CorticosteroneIBA 11/2017
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 05/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2015
1	Sirolimus (Rapamycin)FDA Link 01/2015
1	AntioxidantsIBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 01/2015
1	LigandsIBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	WD repeat containing planar cell polarity effectorIBA 09/2014
1	Keratins (Keratin)IBA 09/2014
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 08/2014
1	Aquaporins (Water Channels)IBA 07/2014
1	Protective AgentsIBA 01/2013
1	Troponin T (Troponin T1)IBA 01/2013
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2013
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2013
1	GinsenosidesIBA 01/2013
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2012
1	CholesterolIBA 07/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2010
1	PPAR alphaIBA 11/2009
1	Fenofibrate (CiL)FDA LinkGeneric 11/2009
1	SodiumIBA 06/2009
1	Fibrinogen (Factor I)FDA Link 06/2009
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2009
1	PlasminogenIBA 11/2008
1	oxidized low density lipoproteinIBA 11/2008

Therapy/Procedure

5	Radiotherapy 02/2021 - 07/2014
4	Therapeutics 01/2019 - 01/2007
2	Chemoradiotherapy 02/2017 - 01/2016
2	Lung Transplantation 01/2015 - 01/2015